Dermata Therapeutics, Inc. Common Stock (DRMA)
Dermata Therapeutics, Inc. Common Stock (DRMA) has reported earnings 18 times since Sep 27, 2021. The stock moves an average of ±91.12% the day after reporting, closing higher 66.7% of the time. Its largest post-earnings gain was +1534.35% (May 15, 2024) and its largest decline was -14.29% (Mar 26, 2026). The next earnings report is predicted for 2026-08-10 (estimated).
Earnings reactions
How DRMA moved on each past earnings report.
Earnings Impact
Total Earnings
18
Avg Abs. Movement
±91.12%
Positive %
66.7%
Negative %
33.3%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 13, 2026 | ☽ POST | +1.6% | open_in_new |
| Mar 26, 2026 | ☽ POST | -14.29% | open_in_new |
| Nov 14, 2025 | ☽ POST | -9.24% | open_in_new |
| Aug 13, 2025 | ☽ POST | -2.3% | open_in_new |
Earnings Count
18
Total earnings in dataset
Avg Abs. Movement
±91.12%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260616 | open_in_new SEC.gov |
| S-8 | 20260604 | open_in_new SEC.gov |
| SCHEDULE 13D | 20260601 | open_in_new SEC.gov |
| EFFECT | 20260529 | open_in_new SEC.gov |
| 424B3 | 20260529 | open_in_new SEC.gov |
| 8-K | 20260527 | open_in_new SEC.gov |
| S-3/A | 20260522 | open_in_new SEC.gov |
| 10-Q | 20260513 | open_in_new SEC.gov |
| 8-K | 20260513 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260513 | open_in_new SEC.gov |
Frequently asked about DRMA earnings
When does Dermata Therapeutics, Inc. Common Stock report earnings next? expand_more
Dermata Therapeutics, Inc. Common Stock (DRMA)'s next earnings date is estimated for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does DRMA stock move after earnings? expand_more
Over 18 reports, DRMA has moved an average of ±91.12% the session after earnings, closing higher 66.7% of the time.
What was DRMA's biggest post-earnings move? expand_more
DRMA's largest post-earnings gain on record was +1534.35% on May 15, 2024, and its largest decline was -14.29% on Mar 26, 2026.
Where can I find Dermata Therapeutics, Inc. Common Stock's SEC filings? expand_more
All of Dermata Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- ALICO, INC. (ALCO) earnings 2026-08-07
- ASCENT INDUSTRIES CO. (ACNT) earnings 2026-08-07
- Aclaris Therapeutics, Inc. (ACRS) earnings 2026-08-07
- ACV Auctions Inc. (ACVA) earnings 2026-08-07
- ADC Therapeutics SA (ADCT) earnings 2026-08-07
- ADMA BIOLOGICS, INC. (ADMA) earnings 2026-08-07
- Aeva Technologies, Inc. (AEVA) earnings 2026-08-07
- Agenus Inc. Common Stock (AGEN) earnings 2026-08-07